Challenges and opportunities for the implementation of the Three Rs in Canadian vaccine quality control

Mara E Long1, Gilly Griffin

  • 1Canadian Council on Animal Care, 1510-130 Albert Street, Ottawa, Ontario, Canada K1P 5G4. mara.elizabeth1@gmail.com

Insights

Implementing the Three Rs (Replacement, Reduction, and Refinement) in Canadian vaccine testing faces challenges like regulatory hurdles but offers opportunities through harmonization and ethical considerations for animal welfare.

Area of Science:

  • Veterinary medicine
  • Toxicology
  • Biotechnology

Background:

  • The Three Rs principles aim to minimize animal use in scientific research and testing.
  • Vaccine testing traditionally relies on animal models, raising ethical and scientific questions.
  • Implementing alternative methods in vaccine quality control is a growing global trend.

Purpose of the Study:

  • To identify opportunities and challenges in implementing the Three Rs in Canadian vaccine testing.
  • To understand stakeholder perspectives on adopting alternative methods in vaccine quality control.

Main Methods:

  • A case-study approach was employed.
  • Data collected through interviews with 16 Canadian stakeholders in vaccine production, testing, and evaluation.

Main Results:

  • Key challenges include inconsistent regulatory requirements, limitations of in vitro methods, benchmarking issues, and resistance to change.
  • Opportunities identified: harmonization of test methods, collaborative development, poor performance of traditional animal methods, regulatory acceptance, and ethical concerns for animal welfare.
  • Stakeholders express openness to the Three Rs, provided methods are reliable and biologically relevant.

Conclusions:

  • Canadian industry and government are receptive to implementing the Three Rs in vaccine quality control.
  • Successful implementation hinges on the reliability and biological relevance of alternative methods.
  • Harmonizing regulatory requirements is crucial for advancing the adoption of alternative methods in vaccine testing.

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...